UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025975
Receipt number R000028176
Scientific Title Exploratory study of optimal conditions of non-invasive brain stimulation for intractable pain
Date of disclosure of the study information 2017/03/01
Last modified on 2020/02/05 12:05:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study of optimal conditions of non-invasive brain stimulation for intractable pain

Acronym

Exploratory study of optimal conditions of non-invasive brain stimulation for intractable pain

Scientific Title

Exploratory study of optimal conditions of non-invasive brain stimulation for intractable pain

Scientific Title:Acronym

Exploratory study of optimal conditions of non-invasive brain stimulation for intractable pain

Region

Japan


Condition

Condition

intractable pain

Classification by specialty

Neurology Anesthesiology Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore optimal conditions of non-invasive brain stimualtion for treating intractable pain, and to investigate safety and feasibility of the long-term application

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pain reduction in VAS
Pain reduction in NRS

Key secondary outcomes

Frequency and duration of shooting pain, if a subject has a shooting pain
Pain reduction in SF-MPQ 2 (Short form of McGill pain questionnaire 2)
PGIC (Patient global impression of change)
Improvement in PDAS (Pain Disability Assessment Scale)
Improvement in EQ-5D
Improvement in PCS (Pain Catastrophizing Scale)
Improvement in HADS (Hospital Anxiety and Depression Scale)
Change in BDI-II


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

6

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Active rTMS, condition 1
single session

Interventions/Control_2

Active rTMS, condition 2
single session

Interventions/Control_3

Active rTMS, condition 3
single session

Interventions/Control_4

Sham rTMS
single session

Interventions/Control_5

Active tDCS
single session

Interventions/Control_6

Sham tDCS
single session

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patients with intractable pain for 6 months or longer
2)Patients with 30mm or more in VAS at baseline
3)Patients with insufficient pain relief, despite receiving drugs for pain, or a history of using drugs for pain
4)Patients with an informed consent given

Key exclusion criteria

1)Patients with dementia (MMSE=<24)
2)Patients with severe aphasia or higher brain dysfunction
3)Patients with a major psychiatric disease
4)Patients with a desire for suicide
5)Patients with a history of epileptic attacks
6)Patients with an implantable cardiac stimulator
7)Patients with an implantable deep brain stimulation devices
8)Patients with an implanted metal in their heads, except for titanium products
9)Pregnant patients
10)Patients who cannot write questionaires
11)Patients without ability of agreements
12)Patients receiving other clinical trials or studies within 6 months before agreements
13)Patients who are considered unsuitable for this clinical trial by a principal or sub investigator
14)Patients with a scalp lesion on the stimulation site (tDCS)

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Youichi Saitoh

Organization

Osaka University

Division name

Department of Neuromodulation and Neurosurgery

Zip code


Address

2-2 Yamadaoka, Suita, Osaka 565-0871, Japan

TEL

+81-6-6210-8435

Email

saitoh@nsurg.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Koichi Hosomi

Organization

Osaka University

Division name

Department of Neuromodulation and Neurosurgery

Zip code


Address

2-2 Yamadaoka, Suita, Osaka 565-0871, Japan

TEL

+81-6-6210-8435

Homepage URL


Email

k-hosomi@nsurg.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University Hospital

Institute

Department

Personal name



Funding Source

Organization

Osaka University, Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 02 Day

Date of IRB

2017 Year 02 Month 15 Day

Anticipated trial start date

2017 Year 03 Month 01 Day

Last follow-up date

2019 Year 03 Month 29 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 02 Month 02 Day

Last modified on

2020 Year 02 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028176


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name